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Aspirinated human platelets labeled with 32P04 showed a 1.7-fold increase in [32P]IP3 when stimulated with 
ADP. ADP-stimulated mobilization of internal Caz+ and phosphorylation of myosin were enhanced in the 
presence of extracellular Caz+ but the increase in IPs was not significantly affected by external Ca*+. The 
Ca2+ ionophore, ionomycin, elevated internal Ca2+ and induced myosin phosphorylation without a detect- 
able change in IPs. These results indicate that the mechanism of ADP stimulation of human platelets is 
similar to that of other platelet agonists and supports the theory that IP3 functions to liberate internal Ca*+. 
(Platelet) Polyphosphoinositide Inositol triphosphate Myosin phosphorylation Ca2+ 
Phosphatidic acid 
1. INTRODUCTION 
Activation of platelets with agonists is thought 
to occur through an elevation of intracellular 
calcium which can now be measured irectly using 
intracellular Ca2+ indicators such as quin2 [l]. 
Agonist-induced rises in cytoplasmic free calcium 
occur in the absence of external calcium indicating 
that calcium can be liberated from internal stores. 
The mechanism by which an agonist acting at the 
plasma membrane can release calcium from inter- 
nal stores was at first obscure. Binding of an 
agonist to a receptor often results in the turnover 
of PI and its phosphorylated derivatives PIP and 
PIP2 [2]. The earliest measurable change in 
phosphoinositides is a rapid breakdown and resyn- 
thesis of PIP2 [2], a characteristic pattern shown to 
occur in platelets stimulated with thrombin and 
PAF [3-51. The cleavage of PIP2 involves a 
Abbreviations: PI, phosphatidylinositol; PIP, phospha- 
tidylinositol 4-phosphate; PIPI, phosphatidylinositol 
4,5-phosphate; IP3, inositol 1,4,5triphosphate; PAF, 
platelet activating factor 
specific phospholipase C and results in the produc- 
tion of diacylglycerol and IPs [2]. Agonist-induced 
IPs release has been demonstrated for thrombin, 
collagen, PAF and vasopressin [6-lo]. IPs has 
been shown to be a potential second messenger and 
link between the activation of plasma membrane 
receptors and the mobilization of calcium from in- 
tracellular reservoirs [ 1 l-l 31. These data strongly 
indicate that agonist-dependent activation of a 
specific phospholipase C results in an increase in 
cytoplasmic concentration of IPs which in turn 
causes an elevation in cytoplasmic Ca2+ necessary 
for subsequent activation of the platelets. 
In recent experiments, Fisher et al. [14] failed to 
detect a hydrolysis of 32P-labeled PIP2 when 
human platelets were stimulated with ADP. Fur- 
thermore, when platelets were labeled with [3H]- 
inositol, these investigations also failed to detect 
an ADP-stimulated increase in [3H]IP3. In a dif- 
ferent set of experiments, they showed that ADP 
stimulated an increase in cytoplasmic Ca2+ in 
platelets loaded with quin2. Since these data pose 
a serious challenge to the idea that IP3 is required 
to release Ca2+ from intracellular stores, we decid- 
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ed to reexamine the question of whether IPs is 
formed during platelet stimulation by ADP. We 
have used both an improved method for measuring 
IP3 formation in 32P-labeled platelets [15] and the 
new intracellular fluorescent Ca2+ indicator fura- 
[ 161 to monitor Ca2+ mobilization and IP3 forma- 
tion in the same cells. We have found that 32P- 
labeled IP3 levels increase almost 2-fold over basal 
levels supporting the idea that IP3 formation is 
necessary for agonist-dependent Ca2+ mobili- 
zation. 
2. MATERIALS AND METHODS 
2.1. Materials 
Hirudin, ADP, inositol triphosphate were ob- 
tained from Sigma (St. Louis, MO). Apyrase was 
a gift of Dr W. Figures of the Thrombosis Res. 
Ctr. Fura- was obtained from Molecular Probes 
(Junction City, OR), ionomycin from Calbiochem- 
Behring (La Jolla, CA) and bovine thrombin was 
from Armour Pharmaceutical (Kankakee, IL). 
2.2. Preparation of 32P04, fura-24abeledplateIets 
Human blood was taken from informed healthy 
volunteers into acid/citrate/dextrose. Platelet-rich 
plasma obtained by centrifugation at 180 x g for 
15 min at ambient temperature was recentrifuged 
(800 x g, I5 min, ambient temperature). The 
platelet pellet was resuspended in 0.5 vol. of 
autologous platelet-poor plasma and incubated 
with 32P04 (0.25 mCi/ml; ICN, Irvine, CA) at 
37°C. After 30 min, fura- and aspirin were added 
to concentrations of 5 PM and 1 mM, respectively, 
and the incubation continued for another 30 min. 
The platelets were isolated from the incubation 
medium by centrifugation (800 x g, 15 min) and 
resuspended in a buffer composed of 145 mM 
NaCl, 5 mM KCl, 1 mM MgS04, 0.5 mM 
NaHzPOb, 5 mM glucose, 10 mM Hepes (pH 7.4), 
0.01 U/ml hiridin and 0.5 ng/ml apyrase. The cell 
suspension was adjusted to a final density of 2 x 
1 O8 cells/ml. 
2.3. Stimulation of platelets and analytical 
procedures 
Prior to all experiments, platelets were checked 
for shape change by addition of 20 pM ADP to the 
platelets in a Payton aggregometer. For all ex- 
perimental determinations, agonists were added to 
a prewarmed (37°C) and stirred platelet suspension 
(2.5 ml) in a Perkin Elmer LS-5 spec- 
trofluorometer. Changes in fura- fluorescence 
were followed using an excitation of 340 nm and 
emission of 510 nm. At various times during the 
Ca2+ transient, the excitation wavelength was 
momentarily switched to 380 nm and the cytosolic 
free [Ca”] was calculated from the ratio of 
340 nm/380 nm fluorescence as described [16,17]. 
Reactions were stopped either by addition of 1 ml 
of ice-cold 2.1 N HC104 for myosin phosphoryla- 
tion and IP3 determinations or, for phospholipid 
determinations, by addition of an aliquot of the 
platelet suspension to 3.75 vols of ice-cold 
chloroform/methanol (1: 2, v/v) containing 
25 mM sodium EDTA. 
Samples treated with HC104 were separated into 
supernatant and pellet by centrifugation at 
10000 x g for 10 min. The pellet was used for 
determination of myosin phosphorylation as 
described [181. The supernatant was neutralized by 
adding an appropriate volume of 6 N KOH and 
the amount of 32P-labeled IP3 formed was deter- 
mined as described [151. Samples for phospholipid 
analysis were resolved oxalate-treated thin layer 
plates (Merck, Darmstadt, silica gel 60) using the 
solvent system, chloroform/acetone/methanol/ 
glacial acetic acid/H20 (40 : 15 : 13 : 12 : 7 by vol.) 
[19]. The resolved phospholipids were detected by 
radioautography and the radioactivity of the perti- 
nent compounds measured by liquid scintillation 
counting. 
3. RESULTS 
3.1. Measurement of ADP-induced inositol- 
triphosphate production 
In our experience, the response of platelets to 
ADP can be variable and dependent on the method 
of platelet isolation. Thus, after labeling the 
platelets with fura- and 32P04, each platelet 
suspension was tested for its shape change 
response to ADP in an aggregometer. The prepara- 
tions that were responsive were studied in the 
fluorometer and, in all cases, stimulation with 
ADP caused an increase in cytoplasmic free Ca2+. 
The same samples in which Ca2+ mobilization was 
determined were used to measure levels of 32P- 
labeled IP3 and myosin phosphorylation. The 
results of 5 experiments are summarized in fig.1. 
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ADP induced a rapid increase in IP3 to about 
1.7-fold above the basal level in 5 s. A paired Stu- 
dent’s t-test of this data showed that at all times 
the increase was statistically significant at least at 
the 95% level and that the initial rise (t = 5 s) was 
significant at the 99.5% confidence level. For com- 
parison, thrombin (1 U/ml) in a single experiment 
was found to cause a 3.2-fold increase in IP3 in 5 s 
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Fig.1. Time course of ADP-induced IFS formation, 
Ca2+ mobilization and myosin phosphorylation. All 
experiments were done using 20pM ADP on the same 
set of platelet samples. The bars indicate SD of 5 
experiments. For IP3 determinations, significance at any 
time relative to basal is indicated: * p < 0.5; ** p < 0.01; 
We have shown that ADP stimulation of 
aspirinated human platelets is able to induce an in- 
crease in both 32P-labeled IP3 and 32P-labeled PA. 
The magnitudes of these increases are both ap- 
prox. 6-fold lower than produced by 1 U/ml 
thrombin and are consistent with the generally ac- 
cepted view that ADP is a weak agonist compared 
to thrombin. However, since thrombin liberates 
sufficient IPS to achieve an intracellular concentra- 
tion of greater than 10 /IM [7,15], stimulation with 
ADP would produce enough IP3 to nearly saturate 
the IP3 sensitive internal store of platelets which 
has a K, of 1 pM in saponized platelets [ 131. The 
lower level of phosphoinositide metabolism induc- 
ed by ADP can explain the lack of an initial 
decrease in PIP2. At a lower level of phospholipase 
C activation, the hydrolysis of PIP2 may be com- 
pensated by resynthesis from PI. 
***p < 0.005. Both the ADP-stimulated increase in in- 
and a maximum 9.2-fold increase at 60 s. The 
ADP-induced increase in IP3 was paralleled by 
rapid changes in both cytoplasmic Ca2+ levels and 
myosin phosphorylation. The increase in internal 
Ca’+ and the extent of myosin phosphorylation 
were dependent on extracellular Ca”, differences 
for myosin phosphorylation that were statistically 
significant at 10, 30 and 60 s. In contrast, there 
was no statistical significance between the ADP- 
induced increase in IP3 levels in the presence or 
absence of external Ca2+. In addition, 200 nM 
ionomycin elicited a greater increase in 
cytoplasmic Ca *+ than ADP and comparable levels 
of myosin phosphorylation but caused no signifi- 
cant increase in IP3 formation (103 f 15% at 5 s 
and 101 f 20% at 10 s; n = 6). 
3.2. ADP-induced changes in phosphoinositide 
metabolism 
ADP caused neither an increase nor decrease in 
32P-labeled PIP or PIP2 (table 1) confirming the 
results of Fisher et al. [14]. In contrast, a slight in- 
crease in 32P-labeled PI (about 25%) was detected 
and more strikingly (table l), ADP caused a 
2.2-fold increase in 32P-labeled PA. By com- 
parison, thrombin (1 U/ml) was found to increase 
the 32P-labeled PA level about 17-fold in 2 min in 
platelets from the same group of donors. 
4. DISCUSSION 
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Table 1 
Changes in platelet phosphoinositides induced by ADP compared to thrombin and ionomycin 
Agonist Phospholipid 5s 10 s 30 s 60 s 120 s 
ADP 
PIP2 99 f 11 107 f 7 108 f 12 105 f 7 102 f 8 
PIP 94+ 9 102* 7 102* 7 106 + 9 109 + 7 
PI 99 + 12 106 f 11 105 l?r 11 109 f 11 123 f 16 
PA 116 f 12 140 + 16 190 f 20 219 f 21 216 f 25 
Thrombin 
PA 310 f 64 510 f 138 993 + 180 1369 f 239 1731 f 271 
Ionomycin 
PA 101 f 12 109 f 9 lOO* 8 124 f 10 115 f 14 
Results are expressed as mean percentages of resting levels + SD of 4 determinations for ADP 
(20 PM), 2 for thrombin (1 U/ml) and 3 for ionomycin (200 nM) 
tracellular Ca2+ and myosin phosphorylation were 
enhanced in the presence of extracellular Ca2+. In 
contrast, the level of IP3 produced in these cells 
was not greatly affected by the extracellular Ca2+ 
concentration. These results suggest hat IP3 was 
not produced as a consequence of Ca2+ mobiliza- 
tion but rather is consistent with a causal role for 
IP3 in Ca2+ mobilization. Furthermore, ionomycin 
which increases intracellular Ca2+ by bypassing 
receptor-dependent mechanisms does not increase 
either PA [20] or IP3. 
The failure of Fisher et al. [14] to detect an 
ADP-stimulated increase in IP3 cannot be at- 
tributed solely to our use of a more sensitive 
method to measure IP3 since we were able to detect 
an increase in 32P-labeled PA by a similar tech- 
nique to that used by Fisher et al. [14]. In our ex- 
periments, we measured both Ca2+ mobilization, 
myosin phosphorylation and IP3 in the same 
samples thereby assuring internal consistency and 
identical cellular responsiveness. In the studies of 
Fisher et al. [14], Ca’+-mobilization and IP3 
release were measured in different preparations of 
platelets. 
Vickers et al. [21] studying rabbit platelets found 
that ADP did cause a significant decrease in PIP2. 
Other platelet agonists, which appear to be only 
quantitatively different from ADP, have been 
shown to cause increases in IP3. Rather than in- 
voking different mechanisms for different 
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agonists, it is more satisfactory to propose that on- 
ly one basic mechanism of stimulus-response 
coupling is operative for all agonists and while 
there may be quantitative differences between 
platelets from different mammalian species, the 
cells are qualitatively similar. The data presented 
here demonstrate that ADP conforms to the pat- 
tern common to other platelet agonists. 
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